Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Legend Biotech in Somerset, NJ seeks a Principal Scientist, Bioinformatics to lead AI-driven target discovery and binder design for CAR-T therapies. You will develop generative AI models, apply geometric deep learning, and integrate multi-omics data to identify tumor-specific targets.
The role requires a PhD and 3+ years post-PhD in biotech or related field, strong Python/PyTorch expertise, and hands-on experience with AlphaFold, RFdiffusion, ProteinMPNN and other structural biology tools to
Legend Biotech is seeking a Principal Scientist, Bioinformatics as part of the Research & Development team based in Somerset, NJ.
Legend Biotech is at the forefront of developing innovative cell-based therapies. We are seeking a highly motivated and innovative Principal Scientist of Bioinformatics with focus on AI for Drug Discovery & Protein Engineering to join our multidisciplinary R&D team. In this role, you will be a key driver in development of generative AI models and agentic AI systems to discover novel disease targets. Concurrently, you will apply geometric deep learning and structural biology principles to design and refine high-affinity binders (such as scFvs, VHHs, or novel scaffolds) specifically tailored for CAR-T cell therapies.
#Li-JR1
#Li-Onsite
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta‑cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice .